🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Chemoembolization kills tumor cells by blocking the blood flow t...
Status
Completed
Location
Northwestern University, Northwestern Memorial Hospital
Start Date
2009-08
Trial ID
NCT00956930
Treatments Being Tested
This is an open-label multi-center trial designed to evaluate the efficacy ...
Status
Unknown
Location
Indiana University Melvin and Bren Simon Cancer Center
Start Date
2017-03-28
Trial ID
NCT03099564
Treatments Being Tested
This study is open to patients with primary HCC who cannot be treated by po...
Status
Completed
Location
Universitäts-Klinikum München-Grosshadern, Medizinische Klinik und Poliklinik II
Start Date
2006-03
Trial ID
NCT00867750
Treatments Being Tested
This clinical trial will be conducted as a single-center, open-label, Phase...
Status
Terminated
Location
University of Iowa Hospitals and Clinics
Start Date
2020-10-05
Trial ID
NCT04108481
Treatments Being Tested
The objective of this study is to examine critical aspects of radiation exp...
Status
Recruiting
Location
University of Tennessee Medical Center
Start Date
2018-06-19
Trial ID
NCT03686709
Treatments Being Tested
This phase II trial studies the effects of radioembolization with yttrium Y...
Status
Withdrawn
Location
Emory University Hospital/Winship Cancer Institute
Start Date
2022-08-17
Trial ID
NCT05315687
Treatments Being Tested
The purpose of this study is to study the way radioembolization works by co...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2020-12-07
Trial ID
NCT04668872
This is a pilot feasibility study designed to investigate the alterations i...
Status
Completed
Location
University of California, San Francisco
Start Date
2018-04-13
Trial ID
NCT04054908
This study will enroll patients with hepatocellular carcinoma being planned...
Status
Completed
Location
UT Southwestern Medical Center
Start Date
2022-11-04
Trial ID
NCT04459468
Treatments Being Tested
This phase Ib trial investigates the side effects of durvalumab and tremeli...
Status
Active Not Recruiting
Location
City of Hope Medical Center
Start Date
2021-08-03
Trial ID
NCT04605731
Treatments Being Tested